Literature DB >> 7444828

Analysis of lung volume restriction in patients with respiratory muscle weakness.

A De Troyer, S Borenstein, R Cordier.   

Abstract

We investigated pulmonary mechanics in 25 patients, 9 to 55 years of age, with a variety of generalised neuromuscular diseases and variable degrees of respiratory muscle weakness. The average degree of inspiratory muscle force was 39.2% (range 8-83%) of predicted. The lung volume restriction far exceeded that expected for the degree of muscle weakness: the observed decrement in respiratory muscle force should, theoretically, decrease vital capacity to 78% of its control value, while the mean VC in our patients was only 50% of predicted. Analysis of lung pressure-volume curves indicated that the two principal causes of the disproportionate loss of lung volume were a reduction in lung distensibility probably caused by widespread microatelectasis, and a decrease in the outward pull of the chest wall. Because it reflects both direct (loss of distending pressure) and secondary (alterations in the elastic properties of the lungs and chest wall) effects of respiratory muscle weakness on lung function, we conclude that, in these patients, the vital capacity remains the most useful measurement to follow evolution of the disease process or response to treatment.

Entities:  

Mesh:

Year:  1980        PMID: 7444828      PMCID: PMC471343          DOI: 10.1136/thx.35.8.603

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Effect of chest strapping on regional lung function.

Authors:  G W Sybrecht; L Garrett; N R Anthonisen
Journal:  J Appl Physiol       Date:  1975-11       Impact factor: 3.531

2.  Pulmonary mechanics in fibrosing alveolitis: the effects of lung shrinkage.

Authors:  G J Gibson; N B Pride
Journal:  Am Rev Respir Dis       Date:  1977-10

3.  Diffuse pulmonary granulomatous disease in the dog: relation between pressure-volume behavior and morphologic features.

Authors:  M H Lavietes; B Min; J W Hagstrom; D F Rochester
Journal:  Am Rev Respir Dis       Date:  1977-11

4.  Pulmonary function in Duchenne muscular dystrophy related to stage of disease.

Authors:  S R Inkley; F C Oldenburg; P J Vignos
Journal:  Am J Med       Date:  1974-03       Impact factor: 4.965

5.  Effect of increased lung recoil pressure on maximal expiratory flow in normal subjects.

Authors:  S E Stubbs; R E Hyatt
Journal:  J Appl Physiol       Date:  1972-03       Impact factor: 3.531

6.  Pulmonary function in progressive muscular dystrophy.

Authors:  E J Hapke; J C Meek; J Jacobs
Journal:  Chest       Date:  1972-01       Impact factor: 9.410

7.  [New theoretical values in exploration of the respiratory function of the lung].

Authors:  R Amrein; R Keller; H Joos; H Herzog
Journal:  Bull Physiopathol Respir (Nancy)       Date:  1970 Apr-Jun

8.  Pulmonary mechanics in patients with respiratory muscle weakness.

Authors:  G J Gibson; N B Pride; J N Davis; L C Loh
Journal:  Am Rev Respir Dis       Date:  1977-03

9.  Respiratory muscle function in amyotrophic lateral sclerosis.

Authors:  S M Kreitzer; N A Saunders; H R Tyler; R H Ingram
Journal:  Am Rev Respir Dis       Date:  1978-03

10.  Mechanisms determining residual volume of the lungs in normal subjects.

Authors:  D E Leith; J Mead
Journal:  J Appl Physiol       Date:  1967-08       Impact factor: 3.531

View more
  35 in total

1.  Assessment of patient-ventilator breath contribution during neurally adjusted ventilatory assist.

Authors:  Giacomo Grasselli; Jennifer Beck; Lucia Mirabella; Antonio Pesenti; Arthur S Slutsky; Christer Sinderby
Journal:  Intensive Care Med       Date:  2012-05-15       Impact factor: 17.440

Review 2.  Sleep-disordered breathing in patients with neuromuscular disease.

Authors:  Mohamad Ammar Albdewi; Giuseppe Liistro; Riëm El Tahry
Journal:  Sleep Breath       Date:  2017-07-12       Impact factor: 2.816

3.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

4.  Respiratory Muscle Strength as a Predictive Biomarker for Survival in Amyotrophic Lateral Sclerosis.

Authors:  Michael I Polkey; Rebecca A Lyall; Ke Yang; Erin Johnson; P Nigel Leigh; John Moxham
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

5.  Respiratory Muscle Assessment in Acute Guillain-Barré Syndrome.

Authors:  S Walterspacher; A Kirchberger; J Lambeck; D J Walker; A Schwörer; W D Niesen; W Windisch; F Hamzei; H J Kabitz
Journal:  Lung       Date:  2016-08-09       Impact factor: 2.584

6.  Airway dysfunction in patients with Parkinson's disease.

Authors:  J L Izquierdo-Alonso; F J Jiménez-Jiménez; F Cabrera-Valdivia; M Mansilla-Lesmes
Journal:  Lung       Date:  1994       Impact factor: 2.584

7.  Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies.

Authors:  N M Braun; N S Arora; D F Rochester
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

8.  Distribution of pulmonary cholinergic nerves in the rabbit.

Authors:  A W El-Bermani; E I Bloomquist; J A Montvilo
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

9.  Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies.

Authors:  Lauren A Henderson; Stephen H Loring; Ritu R Gill; Katherine P Liao; Rumey Ishizawar; Susan Kim; Robin Perlmutter-Goldenson; Deborah Rothman; Mary Beth F Son; Matthew L Stoll; Lawrence S Zemel; Christy Sandborg; Paul F Dellaripa; Peter A Nigrovic
Journal:  J Rheumatol       Date:  2013-02-01       Impact factor: 4.666

10.  The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis.

Authors:  P Rieder; M Louis; P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.